Areas of Expertise
Entrepreneurship, Starting a Small Business, Virtual Drug Development, Compliance and Regulatory Strategy, Technical Transfer, Due Diligence Assessments

Dr. Blomberg owns Quality CMC Consulting, a pharmaceutical development consulting company, helping global clients with chemistry, manufacturing, and controls (CMC) related activities for both small molecule and biologic programs. She directs outsourced drug development activities and guides clients on building internal systems that are streamlined for their phase of development and business model. Projects include Chiesi USA for market approval of Retavase® and PvP Biologics who was acquired by Takeda for $330 MM. She also assists clients with due diligence M&A activities. Prior to starting Quality CMC Consulting in Dec-2012, she worked for small-to-mid sized companies in RTP, NC. Dr. Blomberg received her Ph.D. in Analytical Chemistry from Duke University and received the Scholarship in `96-98 while attending UCF. She is the co-inventor of multiple patents and provides training to the industry. She currently is an ASF mentor and sits on the ASF Program Committee and Strategic Planning Task Force.